Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia
Journal of Addictive Diseases – August 04, 2023
Source: OpenAlex
Summary
The emerging trend of vaping the Hallucinogen Psilocybin presents significant concerns for Medicine and Psychiatry. Its growing use, particularly among individuals consuming Amphetamine-Type Stimulants and across broader Demography, highlights a critical gap in understanding. Forensic Toxicology and Drug Analysis reveal this rise. Unlike some insights from Cannabis and Cannabinoid Research, knowledge regarding Psilocybin's long-term health effects remains severely limited. Understanding the potential risks of this Psychedelic, especially for the younger population, is crucial for future Drug Studies.
Abstract
Psilocybin in vaping is growing among ATS users and across all populations. Unfortunately, knowledge regarding the long-term effects on health is limited. Further studies should highlight the harmful effects of psilocybin and the potential risk of psilocybin vaping among the younger population.